News

SIOG2018 Reward for Study Proposal Thermotherapy for Primary H&N Cancer

Dr. Mandy Kiderlen has been awarded with the SIOG 2018 Young Research Prize for her presentation of the proposal regarding ...
Read More

EBAN votes Sensius Winner of Winter Summit 2018

Luxembourg, 23 October 2018 Members of EBAN, the European Business Angel Network, voted Sensius to be the winner of the ...
Read More

Sensius Winner of Dutch Start JLM2018 competition

The Israeli ambassador, His Excellence Aviv Shir-On, presented the winner's plaque to Sensius after a pitching contest at the brand ...
Read More

Germany adds Hyperthermia to Treatment of Sarcomas in Certification Pilot

The most recent questionnaire for sarcoma centers as published by the DKG, the German Cancer Society, now includes the requirement ...
Read More

Maarten Paulides appointed Scientific Director C3TE TU-Eindhoven

The Technical University Eindhoven has appointed Maarten Paulides, co-founder of Sensius, to be the new scientific director of the Center ...
Read More
Sensius: First joint EBAN Scaleup of the month May-2018

Sensius: First joint EBAN Scaleup of the month May-2018

31 May 2018 On May 31, 2018 the European Business Angels Network (EBAN) and the European Agency for Small and ...
Read More
2nd Annual ESHO Sensius Young Investigators Award

2nd Annual ESHO Sensius Young Investigators Award

19 May, 2018 Sensius is sponsor of the European Society for Hyperthermic Oncology (ESHO). During the annual conference in May ...
Read More
New! Advisory Board Sensius

New! Advisory Board Sensius

1 May, 2018 In May 2018 Sensius established an Advisory Board with board members with specific knowledge and experience on ...
Read More

Sensius won the Venture Cup Award of Startup Olé Salamanca

19 April 2018 Sensius won the Venture Cup Award of Startup Olé SalamancaCompanies with the European Seal of Excellence from ...
Read More
Interview Life Sciences & Health 010 magazine

Interview Life Sciences & Health 010 magazine

February 2018 In December 2017 our CEO Paul van den Biggelaar was interviewed by the Life Sciences & Health 010 ...
Read More

Comments are closed.